Frontiers acquires Oncology Reviews journal

The open-access publisher Frontiers has acquired the journal Oncology Reviews from PAGEPress – the first such deal since it was founded in 2007. Oncology Reviews is also Frontiers’ first proprietary reviews journal, aiming to publish 'highly impactful reviews, thought-provoking editorials and opinion pieces'.

Frederick Fenter, chief executive editor of Frontiers, said: 'Our successful experience with supporting the journals of learned societies on our open-science platform has now made it possible to pursue our mission via the strategic acquisition of existing journals. The quality and reputation of Oncology Reviews is excellent, and I look forward to welcoming its outstanding panel of editorial board members and its editor-in-chief, Camillo Porta, to our community.' 

Launched in 1970, Oncology Reviews publishes authoritative reviews on preclinical and clinical aspects of oncology. Commenting on the acquisition, editor-in-chief, Dr. Porta added: 'Working with Frontiers and their open-access platform is an important moment for our journal. I am confident their platform and their passion for quality, collaboration, and open access is the start of something exciting that will enable us to reach new heights.'

Oncology Reviews is a popular choice for authors seeking an impactful venue for Reviews and Mini-Review article types. Among others, it is indexed in The Emerging Sources Citation Index; PubMed Central; Directory of Open Access Journals; and Scopus.